TNF and metabolic syndrome: In conclusion, the results of the current study show that Allo has a protective effect on vascular complications of IR which may be attributed to the effect of Allo on decreasing the level of TNF-α, 4HNE, Ang II, and Ang R1 as well as increasing the level of insulin secretion regardless of the effect of associated dyslipidemia.